The FDA approved first drug to image tau pathology in patients being evaluated for Alzheimer’s disease
On May 28, 2020, the FDA approved Avid Radiopharmaceuticals’ Tauvid (flortaucipir F18) for intravenous injection, the first drug…
On May 28, 2020, the FDA approved Avid Radiopharmaceuticals’ Tauvid (flortaucipir F18) for intravenous injection, the first drug…
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxasï¾’ proprietary High Density…
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the FDA for…
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
On May 27, 2020, the NIH Nutrition Research Task Force (NRTF), armed with insights from the nutrition science…
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
On May 26, 2020, researchers at the Max Planck Institute for Evolutionary Anthropology in Germany and the Karolinska…
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
On May 26, 2020, Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated…
On May 26, 2020, the FDA provided approval to Amivas for its artesunate for injection to treat severe…
On May 26, 2020, University of Nebraska Medical Center (UNMC) researchers were part of a large national study…
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine began the next stage of…
On May 26, 2020, Meridian Bioscience announced that its SARS-CoV-2 antigens and related reagents are part of assays…
On May 26, 2020, Diffusion Pharmaceuticals announced it had received an accelerated response from the FDA to the…
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
On May 21, 2020, the FDA posted list of antibody tests removed from the ‘notification list’ of tests…
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…